ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2016, 'Prognostic significance of hyponatremia in acute intracerebral hemorrhage: Pooled analysis of the intensive blood pressure reduction in acute cerebral hemorrhage trial studies', Critical Care Medicine, 44, pp. 1388 - 1394, http://dx.doi.org/10.1097/CCM.0000000000001628
,2016, 'Prophylactic heparin in acute intracerebral hemorrhage: A propensity score-matched analysis of the INTERACT2 study', International Journal of Stroke, 11, pp. 549 - 556, http://dx.doi.org/10.1177/1747493016641113
,2016, 'Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke', New England Journal of Medicine, 374, pp. 2313 - 2323, http://dx.doi.org/10.1056/NEJMoa1515510
,2016, 'Admission Heart Rate Predicts Poor Outcomes in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies', Stroke, 47, pp. 1479 - 1485, http://dx.doi.org/10.1161/STROKEAHA.115.012382
,2016, 'Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results', Stroke, 47, pp. 1651 - 1653, http://dx.doi.org/10.1161/STROKEAHA.116.013326
,2016, 'Effects of a community-based salt reduction program in a regional Australian population', BMC Public Health, 16, pp. 388, http://dx.doi.org/10.1186/s12889-016-3064-3
,2016, 'Long-term benefits of intensive glucose Control for preventing end-stage kidney disease: ADVANCE-ON', Diabetes Care, 39, pp. 694 - 700, http://dx.doi.org/10.2337/dc15-2322
,2016, 'Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension', Journal of Hypertension, 34, pp. 813 - 821, http://dx.doi.org/10.1097/HJH.0000000000000865
,2016, 'Significance of Hematoma Shape and Density in Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Intracerebral Hemorrhage Trial Study', Stroke, 47, pp. 1227 - 1232, http://dx.doi.org/10.1161/STROKEAHA.116.012921
,2016, 'Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes', Journal of Hypertension, 34, pp. 781 - 787, http://dx.doi.org/10.1097/HJH.0000000000000841
,2016, 'Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis', The Lancet, 387, pp. 957 - 967, http://dx.doi.org/10.1016/S0140-6736(15)01225-8
,2016, 'Genome-wide association studies identify genetic loci associated with Albuminuria in diabetes', Diabetes, 65, pp. 803 - 817, http://dx.doi.org/10.2337/db15-1313
,2016, 'Inaccurate risk perceptions contribute to treatment gaps in secondary prevention of cardiovascular disease', Internal Medicine Journal, 46, pp. 339 - 346, http://dx.doi.org/10.1111/imj.12982
,2016, 'Prediction of 10-year vascular risk in patients with diabetes: The AD-ON risk score', Diabetes, Obesity and Metabolism, 18, pp. 289 - 294, http://dx.doi.org/10.1111/dom.12614
,2016, 'Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage: The INTERACT2 Study', Stroke, 47, pp. 682 - 688, http://dx.doi.org/10.1161/STROKEAHA.115.011627
,2016, 'Significance of Cerebral Small-Vessel Disease in Acute Intracerebral Hemorrhage', Stroke, 47, pp. 701 - 707, http://dx.doi.org/10.1161/STROKEAHA.115.012147
,2016, 'White blood cell count and clinical outcomes after intracerebral hemorrhage: The INTERACT2 trial', Journal of the Neurological Sciences, 361, pp. 112 - 116, http://dx.doi.org/10.1016/j.jns.2015.12.033
,2016, 'Low ambient temperature and intracerebral hemorrhage: The INTERACT2 study', PLoS ONE, 11, pp. e0149040, http://dx.doi.org/10.1371/journal.pone.0149040
,2016, 'Use of antidiabetic and antidepressant drugs is associated with increased risk of myocardial infarction: A nationwide register study', Diabetic Medicine, 33, pp. 218 - 223, http://dx.doi.org/10.1111/dme.12822
,2016, 'Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease', PharmacoEconomics, 34, pp. 195 - 205, http://dx.doi.org/10.1007/s40273-015-0342-3
,2016, 'Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: Updated systematic review and meta-analysis', The Lancet, 387, pp. 435 - 443, http://dx.doi.org/10.1016/S0140-6736(15)00805-3
,2016, 'Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function', Nature Communications, 7, http://dx.doi.org/10.1038/ncomms10023
,2016, 'Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes', Diabetes Care, 39, pp. 2270 - 2277, http://dx.doi.org/10.2337/dc16-1594
,2016, 'Changes in quality of life associated with complications of diabetes: Results from the ADVANCE study', Value in Health, 19, pp. 36 - 41, http://dx.doi.org/10.1016/j.jval.2015.10.010
,2016, 'Determinants and prognostic significance of hematoma sedimentation levels in acute intracerebral hemorrhage', Cerebrovascular Diseases, 41, pp. 80 - 86, http://dx.doi.org/10.1159/000442532
,2016, 'Diabetes and hypertension: Is double therapy useful?', Dialogues in Cardiovascular Medicine, 21, pp. 124 - 135
,2016, 'Is poor oral health a risk marker for incident cardiovascular disease hospitalisation and all-cause mortality? Findings from 172 630 participants from the prospective 45 and up study', BMJ Open, 6, http://dx.doi.org/10.1136/bmjopen-2016-012386
,2016, 'Past decline versus current EGFR and subsequent ESRD risk', Journal of the American Society of Nephrology, 27, pp. 2447 - 2455, http://dx.doi.org/10.1681/ASN.2015060687
,2016, 'Past decline versus current EGFR and subsequent mortality risk', Journal of the American Society of Nephrology, 27, pp. 2456 - 2466, http://dx.doi.org/10.1681/ASN.2015060688
,2016, 'The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: An observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial', BMJ Open, 6, http://dx.doi.org/10.1136/bmjopen-2015-009668
,2016, 'Abstract WMP85: Significance of Cerebral Small Vessel Disease in Acute Intracerebral Hemorrhage: The INTERACT2 Study', Stroke, 47, http://dx.doi.org/10.1161/str.47.suppl_1.wmp85
,2016, 'Abstract WMP91: Hyponatremia is Associated with Higher Mortality in Intracerebral Hemorrhage: Interact 1 and 2 Pooled Analysis', Stroke, 47, http://dx.doi.org/10.1161/str.47.suppl_1.wmp91
,2016, 'Dietary salt intake and discretionary salt use in an Australian population sample: 2011 and 2014', Journal of Nutrition & Intermediary Metabolism, 4, pp. 44 - 44, http://dx.doi.org/10.1016/j.jnim.2015.12.318
,2016, 'OS 34-04 SAFETY OF EARLY INTENSIVE BLOOD PRESSURE LOWERING IN CEREBRAL SMALL VESSEL DISEASE AND CHRONIC KIDNEY DISEASE IN ACUTE INTRACEREBRAL HEMORRHAGE', Journal of Hypertension, 34, pp. e396 - e397, http://dx.doi.org/10.1097/01.hjh.0000501017.61343.bf
,2016, 'PM082 Interventions to Improve Medication Adherence in Coronary Disease Patients: A Systematic Review of Randomised Controlled Trials', Global Heart, 11, pp. e83 - e84, http://dx.doi.org/10.1016/j.gheart.2016.03.289
,2016, 'Smartphone Apps to Improve Medication Adherence', Heart, Lung and Circulation, 25, pp. S331 - S332, http://dx.doi.org/10.1016/j.hlc.2016.06.785
,2016, 'YIA 03-01 VALIDATION OF GENETIC DETERMINANTS OF UNMET NEEDS IN THE TREATMENT OF KIDNEY DISEASE IN TYPE-2 DIABETES', Journal of Hypertension, 34, pp. e204 - e204, http://dx.doi.org/10.1097/01.hjh.0000500440.30977.36
,2015, 'Dietary salt intake and discretionary salt use in two general population samples in Australia: 2011 and 2014', Nutrients, 7, pp. 10501 - 10512, http://dx.doi.org/10.3390/nu7125545
,2015, 'Higher mortality in patients with right hemispheric intracerebral haemorrhage: INTERACT1 and 2', Journal of Neurology, Neurosurgery and Psychiatry, 86, pp. 1319 - 1323, http://dx.doi.org/10.1136/jnnp-2014-309870
,2015, 'Off-Hour admission and outcomes in patients with acute intracerebral hemorrhage in the INTERACT2 trial', Cerebrovascular Diseases, 40, pp. 114 - 120, http://dx.doi.org/10.1159/000434690
,2015, 'Statistical analysis plan for evaluating low- vs. Standard-dose alteplase in the ENhanced Control of Hypertension and Thrombolysis strokE stuDy (ENCHANTED)', International Journal of Stroke, 10, pp. 1313 - 1315, http://dx.doi.org/10.1111/ijs.12602
,2015, 'Endothelial Gata5 transcription factor regulates blood pressure', Nature Communications, 6, http://dx.doi.org/10.1038/ncomms9835
,2015, 'Poor utility of grading scales in acute intracerebral hemorrhage: Results from the INTERACT2 trial', International Journal of Stroke, 10, pp. 1101 - 1107, http://dx.doi.org/10.1111/ijs.12518
,2015, 'Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes', Diabetes Care, 38, pp. 1891 - 1897, http://dx.doi.org/10.2337/dc15-0925
,2015, 'Yoga's effect on inflammatory biomarkers and metabolic risk factors in a high risk population - a controlled trial in primary care', BMC Cardiovascular Disorders, 15, http://dx.doi.org/10.1186/s12872-015-0086-1
,2015, 'Erratum. The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes. Diabetes Care 2014;37:1353-1359', Diabetes Care, 38, pp. 1393, http://dx.doi.org/10.2337/dc15-er07a
,2015, 'Erratum. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients With type 2 diabetes. Diabetes Care 2014;37:295-303', Diabetes Care, 38, pp. 1393, http://dx.doi.org/10.2337/dc15-er07
,2015, 'Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment', International Journal of Stroke, 10, pp. 778 - 788, http://dx.doi.org/10.1111/ijs.12486
,2015, 'Measuring the Progressivity of the Pharmaceutical Benefits Scheme', Australian Economic Review, 48, pp. 122 - 132, http://dx.doi.org/10.1111/1467-8462.12103
,2015, 'Older age is a strong predictor for poor outcome in intracerebral haemorrhage: The INTERACT2 study', Age and Ageing, 44, pp. 422 - 427, http://dx.doi.org/10.1093/ageing/afu198
,